IgniteData And RealTime Partner To Streamline Cancer Data
The companies are integrating platforms to automate clinical data transfers at research sites globally.
Updated on Oct. 15, 2026 in Cancer
Live Poll
Do you believe automating clinical data entry will improve the quality of patient care?
IgniteData and RealTime eClinical Solutions have partnered to integrate their clinical data transfer platforms, allowing for automated data sharing between research sites and sponsors. The collaboration connects RealTime electronic source data systems directly to sponsor electronic data capture systems.
Why it matters
The integration eliminates the need for manual data re-entry, reducing the administrative burden on clinical coordinators. By streamlining data collection, the partnership aims to improve efficiency in oncology research trials.
IgniteData currently operates at 80% of National Cancer Institute-designated cancer centers. The RealTime network supports 3,000 research sites, including nine of the top 10 site networks and three of the top five contract research organizations.
The players
IgniteData
This health technology firm provides clinical data transfer platforms used by the majority of National Cancer Institute-designated cancer centers.
RealTime eClinical Solutions
This company offers a Site Operations Management System that supports thousands of research sites across 30 countries.
The details
The Archer platform now facilitates direct transfers from the RealTime Site Operations Management System to sponsor databases. This automated workflow ensures data is captured once at the source, preventing redundant steps for clinical research personnel.
Timeline
October 15, 2026: The companies announced their partnership for clinical data transfer.
The Big Picture
This integration aligns with the digital interoperability goals prioritized by National Cancer Institute-designated cancer centers to accelerate research outcomes. It marks a shift toward automated data infrastructure in oncology, moving away from legacy manual processing systems.
For participants in clinical trials, this integration potentially reduces errors and speeds up the time it takes for new cancer treatments to move from research to clinical availability. Patients may benefit from faster trial processing as research sites shift from manual documentation to automated systems.
The takeaway
Automating clinical data transfers helps reduce human error and administrative fatigue for research staff. Streamlining these workflows is essential for modernizing trial environments and ensuring more reliable data collection in oncology research.
Further reading
Learn more about the latest innovations in clinical trial methodology on the Cancer section page.
Source note: This article includes information reported by BioXconomy.
Live Poll
Do you believe automating clinical data entry will improve the quality of patient care?
